Migraine: open trials in Canada

20 open trials have a site in Canada. Registry data; only the trial team decides who can take part.

NCT07616128
Study of EVO756 in Adults With Migraine
Trial Treatment · Phase 2 · Evommune, Inc.
Centre de Recherche St-Louis, Québec
Registry updated 2026-11-04
NCT07191145
Eary Infusion of Eptinezumab for TreatmEnt of ACute Post-Traumatic Headaches (ELITE-ACT)
Trial Treatment · Phase 3 · Sunnybrook Health Sciences Centre
Sunnybrook Health Sciences Centre, Toronto
Registry updated 2026-10-29
NCT04649242
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Trial Treatment · Phase 3 · Pfizer
Kelowna Health & Memory Centre, Kelowna BC · Diex Recherche Sherbrooke Inc., Sherbrooke
Registry updated 2026-10-27
NCT04965675
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
Trial Treatment · Phase 3 · H. Lundbeck A/S
Kids Clinic, Ajax · University of Alberta Hospital (UAH), Edmonton · London Health Sciences Centre (LHSC), London · The Medical Arts Health Research Group - Penticton, Penticton · Vancouver Island Health Authority (VIHA) - Multiple Sclerosis (MS) Clinic, Victoria
Registry updated 2026-10-16
NCT05156398
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
Trial Treatment · Phase 3 · Pfizer
Children's and Women's Health Centre of British Columbia, Vancouver
Registry updated 2026-10-14
NCT05164172
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
Trial Treatment · Phase 3 · H. Lundbeck A/S
Kids Clinic, Ajax · London Health Sciences Centre (LHSC), London · Vancouver Island Health Authority (VIHA) - Multiple Sclerosis (MS) Clinic, Victoria
Registry updated 2026-10-14
NCT05897320
A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
Trial Treatment · Phase 3 · H. Lundbeck A/S
Kids Clinic, Ajax · London Health Sciences Centre (LHSC), London · The Medical Arts Health Research Group - Penticton, Penticton · Vancouver Island Health Authority (VIHA) - Multiple Sclerosis (MS) Clinic, Victoria
Registry updated 2026-10-14
NCT06810505
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Trial Treatment · Phase 3 · AbbVie
London Health Sciences Centre - Victoria Hospital & Children's Hospital /ID# 270659, London · McGill University Health Centre - Glen Site /ID# 270662, Montreal
Registry updated 2026-10-09
NCT05711394
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
Trial Treatment · Phase 3 · AbbVie
Stollery Children's Hospital /ID# 249672, Edmonton · London Health Sciences Center- University Hospital /ID# 252979, London · McGill University Health Centre - Glen Site /ID# 247271, Montreal
Registry updated 2026-10-06
NCT06428838
Eptinezumab as an Adjunct to Standard of Care for Migraine in an Acute Emergency Context
Trial Treatment · Phase 3 · Dr George Medvedev
Royal Columbian Hospital, New Westminster · Surrey Memorial Hospital, Surrey
Registry updated 2026-09-30
NCT07772427
Neuromodulation During the Prodrome to Prevent Disabling Migraine Attacks in Youth
Trial Treatment · University of Calgary
Alberta Children's Hospital, Calgary
Registry updated 2026-08-19
NCT06641466
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
Trial Treatment · Phase 3 · Pfizer
Aggarwal and Associates Limited, Brampton · Centricity Research Halifax Multispecialty, Halifax · OCT Research ULC, Kelowna · Centre de Recherche Saint-Louis inc., Lévis · CaRe Clinic, Red Deer · Bluewater Clinical Research Group Inc., Sarnia · Centre for Neurology Studies, Surrey
Registry updated 2026-07-09
NCT07644299
Self-Hypnosis Training for Migraine Management (HYlaMI): A Pilot and Proof-of-Concept Study
Trial Treatment · Ciusss de L'Est de l'Île de Montréal
Centre de recherche de l'Hôpital Maisonneuve-Rosemont (CR-HMR), Montreal
Registry updated 2026-06-12
NCT05306899
Multi-center RCT of IV Ketamine Efficacy and Safety in Chronic Daily Headaches
Trial Treatment · Phase 3 · University Health Network, Toronto
Women's College Hospital, Toronto · Toronto Western Hospital, Toronto
Registry updated 2026-06-08
NCT03972124
Cannabis for the Prophylactic Treatment of Migraine
Trial Treatment · Phase 2 · University of Calgary
CHAMP Research (Calgary Headache Assessment & Management Program), Calgary
Registry updated 2026-05-01
NCT07368140
Exploring Mild Electrical Vestibular Stimulation as a New Treatment for Dizziness and Migraine Symptoms
Trial Treatment · University of Calgary
Human Performance Laboratory, University of Calgary, Calgary
Registry updated 2026-01-26
NCT05158894
Observational Study to Assess Adverse Events When Adult Female Participants Are Treated With Ubrelvy (Ubrogepant) or Qulipta (Atogepant) During Pregnancy
Research · AbbVie
Ottawa Hospital Research Institute /ID# 280174, Ottawa
Registry updated 2025-12-15
NCT07143396
Evaluation of a Mind-Body Based Approach for Chronic Pain Treatment
Trial Treatment · University of the Fraser Valley
University of the Fraser Valley, Chilliwack
Registry updated 2025-09-08
NCT05707949
Long-term Extension Study to Assess Adverse Events of Oral Atogepant Tablets in Pediatric Participants (6 to 17 Years of Age) With Migraine
Trial Treatment · Phase 3 · AbbVie
Stollery Children's Hospital /ID# 251426, Edmonton · Montreal Children's Hospital /ID# 250649, Montreal
Registry updated 2025-08-11
NCT05337033
Cannabis for Chronic Headaches in Adolescents: the CAN-CHA Trial
Trial Treatment · Phase 2 · University of Manitoba
Dalhousie University, Halifax · North Toronto Neurology, Toronto · University of British Columbia, Vancouver
Registry updated 2025-05-29

All Migraine trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error